Associate Medical Director

Sanofi•Cambridge, MA

18h•$148,500 - $214,500•Onsite

About The Position

As within our Global Respiratory Franchise, you’ll play a pivotal role in shaping post-marketing medical evidence generation for dupilumab across asthma and COPD indications. This is a unique opportunity to drive meaningful patient impact through rigorous clinical and real-world evidence, while collaborating with world-class experts across a dynamic, matrixed global organization. Ready to get started? Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. About Sanofi: We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

Requirements

Graduate degree in a relevant scientific or medical discipline (MD, PhD, PharmD, or Master's in a relevant scientific field)
Minimum of 5 years of industry experience in the pharmaceutical, biopharmaceutical, or biotechnology industry in R&D, Medical Affairs, or a related field
Experience operating within complex matrixed organizational environments
Strong scientific communication and presentation skills

Nice To Haves

Demonstrated experience in clinical trial methodology, design, and execution including Phase IV, observational, or real-world evidence studies
Experience in a global or regional medical or clinical development role
Experience in biologics within respiratory, immunology, or immune inflammation therapeutic areas
Experience with dupilumab, asthma, or COPD
Experience in alliance or partnership settings

Responsibilities

Support the development and execution of the Integrated Evidence Generation Plan and Global Medical Strategy for dupilumab in asthma and COPD.
Design clinical study synopses for Phase IV studies, including both interventional, observational, and real-world evidence (RWE) studies.
Partner with regional and local affiliates to support their evidence generation plans and studies, ensuring alignment with the Global Medical Plan.
Evaluate and support external sponsored research initiatives, maintaining scientific rigor and strategic relevance.
Build and maintain strong relationships with respiratory experts, academics, patient associations, and key opinion leaders to inform clinical development strategy.
Support advisory boards and roundtables to gather strategic insights that shape medical, scientific, and development priorities.
Ensure a patient-centric approach in the design and execution of all clinical studies, collaborating closely with the alliance to deliver on shared objectives.